ESMO Sarcoma and Rare Cancers Congress 2026

The ESMO Sarcoma and Rare Cancers Congress 2026 will once again serve as a premier forum for sharing groundbreaking research, novel treatment strategies, and fostering collaborations to drive progress in this crucial area of oncology.

Join us from 12–14 March 2026 in the charming city of Lugano, Switzerland, renowned for its stunning lakeside views and rich cultural heritage.

The scientific and educational programme will explore the latest advancements in diagnosis, treatment, biology, and molecular classification of rare solid tumours, ensuring a comprehensive update on the evolving landscape of these complex diseases.

Attendees can engage in Abstract-related sessions, educational lectures, Multidisciplinary Tumour Boards, Special Sessions, Guidelines discussions, and dedicated Young Oncologists sessions, all designed to enhance knowledge and foster interactive discussions.

Whether you are a clinician, researcher, healthcare professional, industry expert, or patient advocate, this congress offers a unique opportunity to connect, learn, and contribute to the future of sarcoma and rare cancer care.

We look forward to welcoming you to Lugano for three inspiring days of scientific exchange and collaboration at the forefront of oncology.

Scientific Co-Chairs

David Thomas Sydney, Australia

Eva Tiensuu Janson Uppsala, Sweden

Claudia Valverde Barcelona, Spain

Organisation

ESMO Head Office
Via Ginevra 4, 6900 Lugano
Switzerland
meetings@esmo.org